Press Release: SpectraMedics USA, 17 December 2007

SpectraMedics USA introduces the MID-Laser, by Irradia.

SpectraMedics specializes in supplying therapeutic lasers to medical, veterinary and rehabilitation professionals worldwide. Highly regarded for our honesty, ethics and integrity, we only represent products which conform to the highest standards of quality, reliability, safety and performance, and which offer outstanding value.

In this tradition, SpectraMedics USA is very pleased to announce the addition of Irradia's MID-Laser to our range.

Founded in 1977, Irradia is a Swedish, family-owned business which develops and manufactures therapeutic, surgical, and cosmetic laser instruments. With 30 years in the fields of laser technology, science, and medicine, Irradia is one of the most trusted and experienced manufacturers of medical and therapeutic lasers in the world.

The scientific advisor of Irradia, Lars Hode, PhD, is a world authority in the field of laser therapy. He has co-authored the widely known and cited reference books “The Laser Therapy Handbook” and “Laser Therapy, Clinical Practice and Scientific Background” (Tunér & Hode, Prima Books, Stockholm, Sweden). Irradia's MID-Laser operates both Continuous Wave and Super-Pulsed therapeutic laser probes. The flagship Super-Pulsed 904nm GaAs multiprobe offers proven efficacy in the treatment of musculoskeletal pain and inflammation, and the stimulation of deep-tissue healing. A growing range of additional probes, offering a variety of power and wavelength options, may be added at any time to broaden the scope of your treatments and keep abreast of new techniques.

As always, service, support and education are key factors in the inclusion of any product in SpectraMedics' range. In conjunction with Irradia, SpectraMedics USA offers MID-Laser users access to ongoing expert clinical, technical and academic support from the entire SpectraMedics and Irradia teams, both local and international, as well as a 3 year product warranty and 48-hour service guarantee.

Further, in keeping with our commitment to promoting laser medicine and photobiomodulation, and in improving the standards of education of practitioners in emerging markets, such as the USA, SpectraMedics is happy to announce its involvement with, and complete support for, the Irradia Education initiative being launched in 2008.

We welcome you to join us at an Irradia Education Seminar soon!

Peter Jenkins
Managing Director

Contact Details

Australia/New Zealand

North America